The global breast imaging market was valued at $3184.22 billion in 2018 & is estimated to generate net revenue of approximately $6258.79 billion by 2027, growing at a CAGR of 7.81% 2027. Growing occurrences of breast cancer are expected to drive the market. The breast imaging market is primarily driven by the following factors:

• The surge in the prevalence of breast cancer
• Increasing awareness regarding cancer screening programs
• Advancements in technology

To know more about this report, request a free sample copy

The important drivers that are enhancing the growth of the global breast imaging market have been the surge in the prevalence of breast cancer and advancements in technology. Breast cancer is the most common invasive cancer in females across the world, being the second most leading cancer in females. Market players are rigorously involved in the development of new technologies and improvement of existing technologies to maintain their hold over the market.

Breast imaging technologies are used extensively for various breast cancer treatments. Breast imaging technologies are bifurcated into ionizing technology and non-ionizing technology. Ionizing technology comprises of Analog Mammography, Positron Emission Mammography, Full-field digital mammography, Cone-beam computed tomography, 3D Breast Tomosynthesis, Electric impedance tomography, Positron Emission Tomography-Computed Tomography (PET-CT) and Molecular Breast-Specific Gamma Imaging (MBSGI) whereas Non Ionizing technology comprises of Breast MRI, Breast Ultrasound, Optical Imaging, Breast Thermography, and Automated whole-breast ultrasound. In full-field digital mammography, x-ray films are replaced with solid-state detectors to record electric signals. Electric impedance tomography technique is very effective for the early detection of breast cancer in both normal breast density patients and dense breast patients. Cone-beam computed tomography uses a divergent, cone-shaped x-ray that helps in obtaining sharp images. Molecular breast-specific gamma imaging (MBSGI) technique uses nuclear medicines to diagnose cancerous cells. Breast MRI system is based on a technology that uses radio waves and magnetic waves to obtain a comprehensive cross-sectional image of the breast. The optical imaging systems use near-infrared (NIR) waves as a continuous wave source.

The high cost of breast imaging technologies and stringent regulatory framework are the major factors hindering the breast imaging market. The high cost of imaging systems is a preliminary restraint for the growth of the breast imaging market. The time to receive regulatory approval for medical devices in the U.S. and Europe usually takes a few years and requires a lot of supportive data.

The Global Breast imaging market segments include technology.

• Technology is segmented into:
  • Ionizing technology
    • Analog mammography
    • Molecular breast-specific gamma imaging (MBSGI)
    • Positron emission mammography
    • Cone-beam computed tomography
    • 3D breast tomosynthesis
    • Full-field digital mammography
    • Electric impedance tomography
    • Positron emission tomography-computed tomography (PET-CT)
  • Non-ionizing technology
    • Breast thermography
    • Breast ultrasound
    • Automated whole-breast ultrasound
    • Breast MRI
    • Optical imaging

This report covers the present market conditions and the growth prospects of the global Breast imaging market for 2019-2027 and considered the revenue generated through the sales of breast imaging for technology to calculate the market size by considering 2018 as the base year.

Geographically, the global breast imaging market has been segmented on the basis of four major regions, which include:

• Breast Imaging North America Market: The United States & Canada
• Breast Imaging Asia-Pacific Market: China, India, Japan, Australia, South Korea & Rest of APAC
• Breast Imaging Europe Market: The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
• Rest of World: Latin America & Middle East and Africa

The breast imaging market in North America is expected to hold the largest share by 2027 possibilities of government support for quality healthcare, high purchasing power parity, and increasing prevalence of breast cancer. For instance, in the U.S., the Patient Protection and Affordable Care Act (PPACA) promote affordability and quality of health insurance and reduce the cost of healthcare for the individual. The U.S. dominated the overall North American breast imaging market owing to the presence of a highly developed healthcare infrastructure, increasing research and development activities in the pharmaceutical and biotechnological sector. North America breast imaging market constitutes approximately 44% share.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the breast imaging market owing to improving healthcare infrastructure coupled with government initiatives and raising awareness. Moreover, economically developing nations such as India and China are attracting the market player, which is further expected to catalyze the market growth.

The major market players of the global breast imaging market are:

• Hologic, Inc.
• Siemens AG
• General Electric Company
• Fujifilm Holdings Corporation
• Philips Healthcare

Company Profiles covers the analysis of important players. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. Philips’ Healthcare Division provides products for breast imaging technologies such as computed tomography, mammography, ultrasound, and molecular nuclear imaging (digital PET/CT).

Key Findings of the global breast imaging market:

• 3D Breast tomosynthesis is the fastest growing ionizing technology
• Breast MRI is the largest revenue generating non-ionizing technology